4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001312326-20-000002
Options or other derivatives
- Director acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Baxter Nicholas W Director | 2020-04-23 | Grant or award · stock options | +150,000 | 150,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…